Avalere Health Advisory is taking an important step to help organizations like the Arthritis Foundation reach EVERY PATIENT POSSIBLE. Avalere Health Advisory will donate its data-driven analysis and consulting services to the Foundation, which is one of the largest nonprofit organizations and serves nearly 60 million adults and hundreds of thousands of children in the U.S.

Avalere Health will focus its pro bono services for the Arthritis Foundation on disease prevalence, progression, and treatment impacts for women as they age. Despite existing research, sex-specific analysis remains limited.

“Through this collaboration, the Arthritis Foundation will be able to identify the critical health challenges affecting women aged 40 and older, particularly those within the Medicare population, with a focus on rheumatoid arthritis and osteoarthritis,” said Laura Housman, Ph.D., Practice Director at Avalere Health.

Avalere Health Advisory’s Pro Bono Grant Initiative is a new program created to offer free data-driven analyses, research, or consulting services to nonprofit, 501(c)(3) organizations.

“There are healthcare organizations that are facing unique challenges in today’s current funding environment,” said Dr. Housman. “This Initiative is our way of ensuring nonprofit groups continue to deliver their services that could have been delayed, cut, or shelved because of limited resources.”

The application cycle for the 2026 Pro Bono Grant Program is now open. Interested applicants can learn about the application process and key dates here.

Applications will be selected based on four evaluation criteria:

• Impact on Underrepresented Populations: Addressing an underrepresented population, location, or disease state.
• Public Reach: Opportunity to increase impact or adoption through highly public or significant work.
• Promotion of Health Equity: Potential to advance health equity, improve access to healthcare, or enhance health outcomes for individuals.
• Relevance to Avalere Health’s Mission: Alignment with Avalere Health’s efforts to reach EVERY PATIENT POSSIBLE.

Recipients of the Avalere Health Advisory’s Pro Bono Grant Initiative will receive services based on their specific needs. The company will not undertake any lobbying activities, including any project that will require Avalere Health or any of its employees to register as a “Lobbyist” under the federal Lobbying Disclosure Act or similar state laws. Any public-facing deliverables will require Avalere Health to retain editorial control and will not include specific recommendations, advocacy, or endorsement of any specific policy position. All deliverables and research will maintain objectivity and will be neutral in tone.